These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Gentamicin. Brief review of current information]. Modr Z; Hejzlar M Cas Lek Cesk; 1970 Apr; 109(17):347-51. PubMed ID: 4393373 [No Abstract] [Full Text] [Related]
3. The clinical use of nalidixic acid. A review and some observations. Stamey TA; Nemoy NJ; Higgins M Invest Urol; 1969 May; 6(6):582-92. PubMed ID: 4976942 [No Abstract] [Full Text] [Related]
4. Laboratory and clinical evaluation of rifampicin. Atlas E; Turck M Am J Med Sci; 1968 Oct; 256(4):47-54. PubMed ID: 4387028 [No Abstract] [Full Text] [Related]
5. [Experimental evaluation of the new cephalosporin antibiotic cephacetrile]. Kradolfer F; Ahrens T; Gelzer J; Vischer W; Zimmermann W Arzneimittelforschung; 1974 Sep; 24(9b):1446-51. PubMed ID: 4154769 [No Abstract] [Full Text] [Related]
6. Cephalothin: antibacterial activity in vitro and treatment of infections in man. Altucci P; Sapio U; Varone GL Chemotherapy; 1967; 12(2):89-100. PubMed ID: 4383219 [No Abstract] [Full Text] [Related]
7. Nalidixic acid in urinary infection. Neogy KN; De MS; Chatterjee ML Bull Calcutta Sch Trop Med; 1968 Jan; 16(1):11-2. PubMed ID: 4890385 [No Abstract] [Full Text] [Related]
8. [Study of nalidixic acid activity on 3186 strains of Gram negative bacilli. Application to the treatment of urinary infections]. Chamfeuil R; Curcier H Presse Med (1893); 1969 Nov; 77(48):1763-4. PubMed ID: 4903534 [No Abstract] [Full Text] [Related]
9. Morphological changes of bacteria induced by chemotherapeutic agents. 3. Matsumae A J Antibiot (Tokyo); 1965 Sep; 18(5):233-42. PubMed ID: 4379209 [No Abstract] [Full Text] [Related]
10. Gentamicin. Clinical and pharmacological studies. Holloway WJ Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):122-7. PubMed ID: 4913081 [No Abstract] [Full Text] [Related]
11. Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria. Atlas E; Clark H; Silverblatt F; Turck M Ann Intern Med; 1969 Apr; 70(4):713-21. PubMed ID: 4977045 [No Abstract] [Full Text] [Related]
13. [Microbiological studies on the combination effect of rifampicin and nalidixic acid (author's transl)]. Ishiyama M; Nakazawa S Jpn J Antibiot; 1974 Oct; 27(5):643-52. PubMed ID: 4218271 [No Abstract] [Full Text] [Related]
14. Clinical and laboratory evaluation of cephalexin in urinary-tract infections. Acar JF; Baudens JG; Chabbert YA Antimicrob Agents Chemother (Bethesda); 1969; 9():398-404. PubMed ID: 4919001 [No Abstract] [Full Text] [Related]
15. [Sensitivity to some antibacterial agents, of the microbial flora isolated from patients with infections of the urinary tract in the years 1964-1967]. Diana L; Romano M; Perin G Ig Mod; 1968; 61(5):292-315. PubMed ID: 4889607 [No Abstract] [Full Text] [Related]
16. Experience with gentamicin and specialty use of gentamicin. Gentamicin: laboratory and clinical experience in Mexico. Escárzaga E J Infect Dis; 1969; 119(4):443-7. PubMed ID: 4977997 [No Abstract] [Full Text] [Related]
17. [Studies on combined action of ampicillin and neggram on gram-negative rods]. Dzierzanowska D; Bobrowski M; Boroń-Kaczmarska A Wiad Lek; 1971 Mar; 24(5):421-6. PubMed ID: 4928217 [No Abstract] [Full Text] [Related]
18. The in vitro activity of cephaloridine. Spectrum, routine sensitivity tests, cross-resistance and inactivation. Hye-Knudsen P Acta Pathol Microbiol Scand; 1966; 66(4):541-50. PubMed ID: 4381136 [No Abstract] [Full Text] [Related]